Breaking: InStride Health raises oversubscribed $30M Series B 97% of graduates show clinical improvement Built on the McLean Anxiety Mastery Program Care across 7 Northeast states & growing Under 1% hospitalization rate after graduation 98% of caregivers would recommend $56M total funding · General Catalyst leads Exposure therapy where fear lives: home, school, the dinner table Breaking: InStride Health raises oversubscribed $30M Series B 97% of graduates show clinical improvement Built on the McLean Anxiety Mastery Program Care across 7 Northeast states & growing Under 1% hospitalization rate after graduation 98% of caregivers would recommend $56M total funding · General Catalyst leads Exposure therapy where fear lives: home, school, the dinner table
InStride Health logo and brand
Exhibit A: a wordmark that promises to walk anxious kids forward, one stride at a time. The pun is intentional. The outcomes are measured.
Company Profile · Pediatric Behavioral Health

InStride Health

The Boston clinic that treats anxiety and OCD in kids - by coaching them through the exact moments most therapy never sees.

Founded 2021 Boston, MA ~180 people $56M raised
Who they are now

A kid stands in a school doorway, frozen. Somebody is on the phone.

The somebody is an exposure coach. The doorway is a real one, on a real Tuesday, in a hallway that has felt impossible for months. This is what InStride Health actually does for a living: it shows up in the moment anxiety wins, and helps a young person walk through it anyway. Not in a waiting room. Not next quarter. Right there.

InStride is a virtual specialty clinic for anxiety and OCD in people ages 7 to 24. It is not a meditation app, not a chat-with-a-coach subscription, and not a directory of therapists who may or may not call you back. It is a licensed clinical program - insurance-backed, outcome-tracked, and built around the unglamorous truth that fear has to be faced in the places it lives.

"Most young people with anxiety never reach the treatment that works. InStride exists to close that gap - not admire it."
7-24ages served
7states (and counting)
4-8month program
3clinicians per kid
Vitals, not vanity metrics. The number InStride cares about most is the one where a kid stops needing them.
The problem they saw

The science was solved. The access was a disaster.

Here is the uncomfortable part. We already know how to treat childhood anxiety and OCD. Cognitive behavioral therapy with exposure and response prevention - ERP - has decades of evidence behind it. The treatment works. The problem is finding anyone trained to deliver it before the waitlist outlasts the childhood.

Specialists cluster in a handful of academic hospitals. Families drive hours, wait months, and pay out of pocket - or they give up. Meanwhile the anxiety compounds: missed school, missed friendships, missed sleep. By the time care arrives, the problem is bigger than it had to be. It is a distribution failure dressed up as a clinical mystery.

"Pediatric anxiety care doesn't have a science problem. It has a delivery problem. InStride decided to be the delivery."- the thesis, plainly stated

And the irony writes itself: the gold-standard treatment requires practicing in the messy real world - the cafeteria, the car, the bathroom sink - yet the system insisted on delivering it inside a quiet office, the one place a child's anxiety conveniently goes silent. InStride looked at that arrangement and asked the obvious question nobody was funding: what if the clinician came to the moment, instead of waiting for the moment to come to the clinic?

The founders' bet

Two clinicians left the best psychiatric hospital in the country to copy their own homework.

Dr. Mona Potter and Dr. Kathryn Boger spent years at McLean Hospital - the Harvard-affiliated institution that routinely tops the U.S. psychiatric rankings - where they co-built the McLean Anxiety Mastery Program. It worked. It also had a ceiling: one building, one waitlist, one region. They had created something excellent and watched most of the families who needed it never get in the door.

So they made a bet. Take the program that worked, rebuild it for virtual delivery, and put it on insurance so a family's zip code and income stop deciding whether their kid gets better. To do it, the clinicians teamed up with CEO John Voith, a healthcare entrepreneur, and CTO James McElhiney, a software engineer - the rare founding table where the people who designed the treatment and the people who could scale it sat down together.

"We aim to expand our specialty clinical services to provide the same care and accessibility we'd want for our loved ones."- John Voith, CEO & Co-Founder

The stride so far

2021
Founded. Four co-founders - two McLean clinicians, an operator, and an engineer - set out to scale proven anxiety and OCD care.
2022
Public launch with $26M. Backed by .406 Ventures, Valtruis, and Mass General Brigham Ventures, with clinical support from McLean Hospital.
2023
Footprint grows. Care expands across the Northeast as the virtual, insurance-based model proves it can travel.
2024
Oversubscribed $30M Series B. General Catalyst leads, joined by existing investors and Hopelab Foundation - total funding reaches $56M.
Now
~180 people, 7 states. Publishing outcomes and pushing into new markets, with Maine on deck.
A timeline with a destination: not "more sessions," but more kids who graduate and don't come back.
The product

One kid. Three clinicians. Zero referral runarounds.

Every InStride patient gets a dedicated care team of three: a therapist, an exposure coach, and a psychiatrist. The therapist runs the treatment plan. The coach does the hard, specific work of real-world exposures - the phone-in-the-doorway moments. The psychiatrist handles medication management without sending the family off to chase a separate referral. Care arrives by text, phone, and video, which means it can reach the kitchen, the classroom, and the car.

Virtual specialty care

Insurance-covered treatment delivered by text, phone, and video - so therapy meets symptoms where they actually happen.

Real-world ERP coaching

Exposure and response prevention practiced in the wild: home, school, restaurants, the community. Not role-played in an office.

Medication management

In-program psychiatry, no outside referral required. The prescriber is already on the team.

Family & school support

Caregiver groups, family involvement, and coordination with schools and referring providers - because anxiety is a household project.

"The program is designed to end. Most kids graduate in four to eight months - the goal is durable skills, not a standing appointment."- on building a clinic that wants to lose customers

That last part is the quiet radical bit. Plenty of behavioral health businesses are built to keep you enrolled. InStride is built to time-box the work and hand the skills over. It treats generalized anxiety, OCD, school refusal, social and separation anxiety, panic, health anxiety, and emetophobia - the whole anxious-kid spectrum - and then, ideally, gets out of the way.

The proof

It publishes its own report card. On purpose.

Behavioral health is famous for vibes over evidence. InStride takes the opposite posture: it runs on measurement-based care and publishes the outcomes. Patients show large, statistically significant reductions in anxiety, depression, and functional impairment. Parents report less family accommodation and less strain. The headline numbers are the kind most clinics would frame and hang - if they tracked them at all.

The outcomes InStride reports

Self-published program data · share of patients / caregivers
Graduates with clinical improvement97%
97%
Caregivers who would recommend98%
98%
Caregivers reporting reduced strain81%
81%
Hospitalized in year after graduation<1%
<1%
The last bar is the one that matters: the closer to empty, the better the year a kid had after leaving.

The credibility isn't only in the spreadsheet. The model descends directly from McLean's program, Mass General Brigham is both a clinical supporter and an investor, and the care coordinates with schools and referring clinicians rather than operating on an island. The investors who wrote the checks - General Catalyst, .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab - are healthcare specialists, not tourists.

"InStride is at the forefront of helping to democratize accessible, high-quality behavioral health care."Holly Maloney · Managing Director, General Catalyst
"We're solving a complex problem - one that requires a diverse, smart, dedicated team."Dr. Mona Potter · CMO & Co-Founder
The mission

Make the best treatment the default, not the exception.

The mission is almost boring in how concrete it is: specialty anxiety and OCD care for ages 7-24 that is accessible, insurance-backed, and scalable. No moonshot language about reinventing the mind. Just a stubborn insistence that the gap between "treatment that works" and "families who can reach it" is a solvable engineering and access problem - and that solving it is the entire job.

"The same care and accessibility we'd want for our loved ones." That is the bar. Everything else is logistics.

For families, the practical version is this: a kid can start care in weeks instead of months, stay on their own insurance, work with specialists who actually do ERP, and finish with skills that outlast the program. For the broader system, InStride is a working argument that high-quality behavioral health doesn't have to be rationed by geography or wealth.

Why it matters tomorrow

Back to the doorway.

Youth anxiety and OCD are not shrinking, and the specialist shortage isn't fixing itself. A model that delivers proven care virtually, bills insurance, coordinates with schools, and proves its results is exactly the kind of thing the system needs more of - and exactly the kind of thing that has been chronically underbuilt. If InStride keeps its outcomes honest as it scales, the question stops being "can virtual specialty care work" and becomes "why was anyone making families wait."

Return to the school doorway. The kid is still standing there, still scared - that part doesn't vanish. But this time there's a plan, a coach on the line, and a clinic that measured this exact moment and built its whole business around it. The kid takes a step. Then another. That is the entire point of the name. InStride didn't make the fear disappear. It made the next stride possible.

Spread the word

Good care deserves better distribution

Find InStride Health

Links & sources

▶ Want to see and hear the model? Search "InStride Health" on YouTube for founder interviews and program walkthroughs, and read the Series B announcement for the full outcomes write-up.
SOURCES: instride.health/about-us · Series B press release · Fierce Healthcare · MedCity News · McLean Hospital · HIT Consultant · Behavioral Health Business